Literature DB >> 8399635

Serum carnitine levels, lipid profile, and metabolic status of patients on continuous ambulatory peritoneal dialysis.

T Pliakogiannis1, C Chatzidimitriou, A Evangeliou, H J Böhles, K Kalaitzidis.   

Abstract

The purpose of our study was to evaluate the influence of serum carnitine levels on the metabolic status and lipid profile of patients on continuous ambulatory peritoneal dialysis (CAPD). We studied the lipid profile, the metabolic status (triceps, skinfold thickness, midarm muscle circumference, relative body weight, serum total protein, albumin), and serum carnitine levels in 22 patients (11 male, 11 female) on CAPD. The results are summarized as follows: mean serum total carnitine (TC) was normal, free carnitine (FC) was reduced, while acylcarnitine (AC) was elevated in our patients (p < 0.001). A positive correlation was found between TC (p < 0.02), FC (p < 0.05), and serum total protein. A positive correlation was also found between TC (p < 0.05), AC (p < 0.02), AC/FC (p < 0.02), and relative body weight, and TC (p < 0.001), FC (p < 0.02), AC (p < 0.01), AC/FC (p < 0.02), and triglycerides. No correlation was found between carnitine and mid-arm muscle circumference, triceps skinfold thickness, albumin, total cholesterol, and HDL- or LDL-cholesterol. Further studies are needed to confirm our results.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399635

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  5 in total

1.  Continuous ambulatory peritoneal dialysis (CAPD) adequacy influences serum free carnitine level.

Authors:  A E Grzegorzewska; I Mariak; A Dobrowolska-Zachwieja
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

2.  L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis.

Authors:  Lorenzo Di Liberato; Arduino Arduini; Claudia Rossi; Augusto Di Castelnuovo; Cosima Posari; Paolo Sacchetta; Andrea Urbani; Mario Bonomini
Journal:  J Nephrol       Date:  2014-03-06       Impact factor: 3.902

3.  Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients.

Authors:  Celalettin Koşan; Lale Sever; Nil Arisoy; Salim Calişkan; Ozgür Kasapçopur
Journal:  Pediatr Nephrol       Date:  2003-10-02       Impact factor: 3.714

4.  Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis.

Authors:  Satoshi Shimizu; Hiroyuki Takashima; Ritsukou Tei; Tetsuya Furukawa; Makiyo Okamura; Maki Kitai; Chinami Nagura; Takashi Maruyama; Terumi Higuchi; Masanori Abe
Journal:  Nutrients       Date:  2019-11-04       Impact factor: 5.717

Review 5.  Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis.

Authors:  Mario Bonomini; Lorenzo Di Liberato; Victor Zammit; Arduino Arduini
Journal:  Molecules       Date:  2019-09-23       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.